Neelima Denduluri, MD of Virginia Cancer Specialists discusses how CDK 4/6 inhibitors are changing the treatment of breast cancer at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
How are CDK 4/6 Inhibitors changing the way breast cancer is treated?
